11.43
price down icon2.39%   -0.28
after-market Handel nachbörslich: 11.24 -0.19 -1.66%
loading

Cartesian Therapeutics Inc Aktie (RNAC) Neueste Nachrichten

pulisher
04:59 AM

Measuring Cartesian Therapeutics Inc.’s beta against major indicesJuly 2025 Recap & Verified Chart Pattern Trade Signals - Newser

04:59 AM
pulisher
02:18 AM

What makes Cartesian Therapeutics Inc. stock price move sharplyInsider Selling & AI Enhanced Trading Alerts - Newser

02:18 AM
pulisher
Aug 13, 2025

How Cartesian Therapeutics Inc. stock performs during market volatilityEarnings Overview Summary & Momentum Based Trading Signals - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Can Cartesian Therapeutics Inc. continue delivering strong returnsPost Earnings Surprise Movers - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

Real time alert setup for Cartesian Therapeutics Inc. performanceProfit Target Planning with Exit Confidence - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Cartesian Therapeutics Reports Positive Q2 2025 Earnings - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Cartesian Therapeutics Inc. stock trend forecastWeekly Chart-Based Forecast for Traders - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Relative strength of Cartesian Therapeutics Inc. in sector analysisFree Market Momentum and Signal Alerts - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionSafe Entry Screening with Data Backed Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Multi factor analysis applied to Cartesian Therapeutics Inc.Free AI Based High Gain Watchlist Scanner - Newser

Aug 10, 2025
pulisher
Aug 08, 2025

Cartesian Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Cartesian Therapeutics 2025 Q2 Earnings Strong Net Income Amid Revenue Decline - AInvest

Aug 08, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian (RNAC) Q2 Revenue Drops 99% - sharewise.com

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics reports second quarter 2025 financial results and provides business update - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics Inc Reports Q2 2025 EPS of $0.51, Surpassing Estimates, with Revenue at $298,000 - GuruFocus

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Cartesian Therapeutics (RNAC) to Release Quarterly Earnings on Thursday - Defense World

Aug 07, 2025
pulisher
Aug 06, 2025

Bank of New York Mellon Corp Boosts Stock Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Aug 06, 2025
pulisher
Aug 06, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $40.00 Average Target Price from Analysts - Defense World

Aug 06, 2025
pulisher
Aug 05, 2025

Design Therapeutics, Inc. shares rise 1.26% intraday as Cartesian Therapeutics reports strong clinical trial progress and global expansion. - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

Cartesian Therapeutics Grants Inducement Awards to New Employees. - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Cartesian Therapeutics Announces New Employee Incentive Grants - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Zacks.com featured highlights Amazon.com, Alphabet and Meta Platforms - The Globe and Mail

Aug 05, 2025
pulisher
Aug 04, 2025

Candlestick Signal Suggests Reversal in Cartesian Therapeutics Inc.Expert Verified Stock Trade Ideas Backed by Data - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Cartesian Therapeutics Inc. Stock Analysis and ForecastBuild wealth faster with disciplined trading - Jammu Links News

Aug 04, 2025
pulisher
Aug 03, 2025

Does Cartesian Therapeutics Inc. stock perform well during market downturnsMaximize returns with smart investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Cartesian Therapeutics Inc. stockUnlock powerful investment tools for free - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Cartesian Therapeutics Inc. stock higher in 2025Get timely alerts on top-performing stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Cartesian Therapeutics Inc. stock expected to show significant growthCapitalize on market shifts before others do - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Cartesian Therapeutics Inc. stock overvalued or undervaluedExceptional trading results - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Can momentum traders help lift Cartesian Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about Cartesian Therapeutics Inc.Free Stock Forecasts For 2025 - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Chart overlay techniques for tracking Cartesian Therapeutics Inc.Free Alert Feed for Momentum Based Picks - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

How to integrate Cartesian Therapeutics Inc. into portfolio analysis toolsRisk-Managed Trade Alerts for Consistency - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Price action breakdown for Cartesian Therapeutics Inc.Free Fast Entry High Potential Stock Alerts - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Progressive Investment Management Corp Reduces Amazon Holdings - The Globe and Mail

Jul 31, 2025
pulisher
Jul 31, 2025

How many analysts rate Cartesian Therapeutics Inc. as a “Buy”Free Stock Target Finder With Proven Results - Jammu Links News

Jul 31, 2025
pulisher
Jul 31, 2025

Technical signs of recovery in Cartesian Therapeutics Inc.Fast Return Equity Forecast With Logic - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Myasthenia Gravis Market Growth to Accelerate in Forecast - openPR.com

Jul 30, 2025
pulisher
Jul 30, 2025

Cartesian Therapeutics Inc. Moves Into Overbought Range Analysts CautiousBuy Alerts With Low Risk Confirmation Noted - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

How to use a screener to detect Cartesian Therapeutics Inc. breakoutsPortfolio Building Plan and Summary Guide - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

New Product Launches: Will They Boost Cartesian Therapeutics Inc. Stock in 2025Entry and Exit Strategy Optimizer Tool Tested - metal.it

Jul 30, 2025
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):